Navigation Links
XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009
Date:3/11/2009

VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced today that its Extraordinary General Meetings ("EGMs") were postponed for one week in accordance with its articles of association due to the absence of a quorum. The postponed EGMs will take place at the Company, Building 3, Kiryat Weizmann Science Park, Rehovot, Israel 76100 at 3:00 p.m. and 5:30 p.m. Israel time on March 18, 2009.

Any proxy votes received at any time up to 48 hours prior to the postponed EGM will be included in the total votes counted for the EGMs. Those shareholders who have a valid "proof of ownership" in Israel or a letter of representation from Computershare, the Company's UK registrars, or a letter of representation from the Bank of NY for an ADR owner, and attend the meeting in person will also be permitted to vote.


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification
2. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
3. Eiger BioPharmaceuticals Raises $7.1 Million A Round
4. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
5. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
6. Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
7. XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
8. XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting
9. XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... the delivery of Brookfield Engineering’s Powder Flow Tester – helping ... a smaller footprint and more compact design. , ... ... ThermoFab, a US-based thermoforming company, has completed the delivery of ... sheet metal to a plastic enclosure with a smaller footprint ...
(Date:12/11/2009)... discovered a new explanation for differences in the severity of ... certain gene, the more serious the handicap. The genetic defect ... it is the amount of copies of the GDI1 gene ... American Journal of Human Genetics , and are the ... to VIB, a life sciences research institute in Flanders, Belgium ...
(Date:12/11/2009)... Gwathmey, Inc., a pre-clinical contract research organization and ... cardiovascular disease announces a new CEO. ... Ph.D., has joined Gwathmey as Chief Executive Officer. ... experience working with small businesses and the federal ... managed multimillion dollar portfolios for the National Institutes ...
Breaking Biology Technology:Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical company ... principally,for use in the hospital setting, announced today ... present the corporate overview on,Thursday, November 1, 2007 ... Time),during the BIOCOM Investor Conference 2007 in San ...
... VICL ) today announced that the company will ... before the opening of,trading on Wednesday, October 31, and ... results and provide a company update at noon,Eastern Time ... a listen-only,basis to any interested parties. The company will ...
... at 2007 AACR-NCI-EORTC International Conference, ... Pharmaceuticals,Inc. (Amex: ANX ), a ... commercializing proprietary product candidates for the ... today it presented preclinical,results demonstrating that ...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007 2Vical Announces News Release and Conference Call Schedule for Third Quarter 2007 Financial Results 2Vical Announces News Release and Conference Call Schedule for Third Quarter 2007 Financial Results 3ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 2ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 3ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 4ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 5
(Date:12/14/2009)... A team of researchers from the Astrobiology Centre (INTA-CSIC) ... considered essential to the formation of the most basic ... blue. In order to carry out this study, published ... scientists recreated the chemical conditions of the early Earth. ... dissolved in ammoniac solutions it produces hydrogen cyanide, a ...
(Date:12/14/2009)... preventing some of the stresses of open surgery on the ... organ dysfunction. Laparoscopy is a type of surgery in the ... By adding another gas to the carbon dioxide used to ... Medical Center have found they can preserve more normal blood ... (ENO) helped to open blood vessels and keep blood flowing, ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2Fabled vegetable lamb plant contains potential treatment for osteoporosis 59458 1Carnegie Mellon researchers save electricity with low power processors and flash memory 10358 1Carnegie Mellon researchers save electricity with low power processors and flash memory 10358 2DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 1DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 2DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 3DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 4DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 5
... hormone known as interleukin-12 (IL-12) can safely be ... experimental therapy for some cancers. , Normally, ... system to attack certain cancers. This strategy, a ... melanoma, advanced kidney cancer and other tumors that ...
... Scientists at the University of Rochester Medical Center have ... neurologic functions in diseases such as Alzheimer's and dementia ... Nov. 1 issue of The Journal of Clinical Investigation, ... brain cells can be damaged during chronic neurodegenerative diseases. ...
... body's primary strategies for regulating its genome is a ... called microRNAs, or miRNAs. First observed only a few ... itself responsible for translating genes into proteins. Scientists have ... players on the genetic field despite having gone unnoticed ...
Other Biology News:Study shows combination of immune substances to be safe 2Scientists show how thinking can harm brain cells 2Scientists show how thinking can harm brain cells 3Twin molecular scissors link creation of microRNAs with gene-silencing 2
... Mouse NIH / 3T3 cells were cultured ... at the log phase of growth. In ... forms, cells were fixed in acetone-methanol. The ... adhesive coated slide, with each wells surface specifically ...
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
... EPICENTREs patented MasterAmp™ 10X PCR Enhancer ... and allows improved sensitivity and specificity ... Using MasterAmp PCR Enhancer in PCR ... DNA melting, increases enzyme?s thermal stability, ...
... Two sizes available for use with 96- or 384-well ... 96 for ease of location on 96-tube plates ... the skirt of the plate* Efficient sealing is ... in conjunction with screw or clip-down hot lid thermal ...
Biology Products: